Raban Jeger

Trials

Studies that name Raban Jeger as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:26 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT07363161 · BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD)

  B. Braun Melsungen AG · recruiting · Coronary Artery Disease (CAD) · principal investigator
• Ph2
  NCT05145283 · Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation

  University Hospital, Basel, Switzerland · completed · Acute Ischemic Stroke, Acute Renal Injury · principal investigator
• N/A
  NCT04881578 · Atrial Fibrillation Before and After Patent Foramen Ovale Closure Study

  Raban Jeger · active not recruiting · Cryptogenic Stroke, Foramen Ovale, Patent, Atrial Fibrillation · principal investigator
• Ph4
  NCT00595647 · Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions

  University Hospital, Basel, Switzerland · terminated · Coronary Artery Disease · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 05:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.